Tori N. Yamamoto

ORCID: 0000-0003-1965-7822

Also affiliated with University of California, San Francisco

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Evaluation of SARS-CoV-2 serology assays reveals a range of test performance”.

Evaluation of SARS-CoV-2 serology assays reveals a range of test performance

Nature Biotechnology(2020)10.1038/s41587-020-0659-0

N/A

15.0DataRank · unranked

299 citations

Joseph Hiatt, Cody T. Mowery, Brian R. Shy, Ruby Yu, Tori N. Yamamoto +67 more

Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive Immunotherapies

Cancer Cell(2020)10.1016/j.ccell.2020.05.004

N/A

0DataRank · unranked

159 citations

Amanda N. Henning, Tori N. Yamamoto, Zhiya Yu, Nikolaos Zacharakis, Sri Krishna +13 more

An engineered IL-2 partial agonist promotes CD8+ T cell stemness

Nature(2021)10.1038/s41586-021-03861-0

N/A

0DataRank · unranked

180 citations

Zhiya Yu, Peng Li, Jangsuk Oh, Rosanne Spolski, Liang Zhao +18 more

Cancer genes disfavoring T cell immunity identified via integrated systems approach

Cell Reports(2022)10.1016/j.celrep.2022.111153

N/A

0DataRank · unranked

15 citations

Shashank J. Patel, Amy E. Decker, Suman K. Vodnala, Maggie Cam, Tori N. Yamamoto +17 more

Modular pooled discovery of synthetic knockin sequences to program durable cell therapies

Cell(2023)10.1016/j.cell.2023.08.013

N/A

0DataRank · unranked

65 citations

Yan Yi Chen, Ryan Apathy, Bence Dániel, Andy Y. Chen, Peixin Amy Chen +21 more